This page includes the latest FDA filings for Macrogenics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | MGNX | DUNS 010626351 |
Device Company | Device | Date |
---|---|---|
MacroGenics, Inc, AGC Biologics, Inc., Baxter Pharmaceutical Solutions, LLC, Eurofins Lancaster Laboratories, Inc | Prescription Medication | 2023-06-02 |
MacroGenics, Inc, AGC Biologics, Inc., Baxter Pharmaceutical Solutions, LLC, Eurofins Lancaster Laboratories, Inc | Prescription Medication | 2021-11-06 |
MacroGenics, Inc, AGC Biologics, Inc., Baxter Pharmaceutical Solutions, LLC, Eurofins Lancaster Laboratories, Inc | Prescription Medication | 2021-01-23 |
MacroGenics, Inc | MARGENZA | 2021-01-15 |
MacroGenics, Inc, AGC Biologics, Inc., Baxter Pharmaceutical Solutions, LLC, Eurofins Lancaster Laboratories, Inc | Prescription Medication | 2021-01-15 |
MACROGENICS INC | 2020-12-22 23:10:48 |
NCAGE Code | 3PTZ3 | MACROGENICS, INC. |
CAGE Code | 3PTZ3 | MACROGENICS, INC. |
S.A.M. Registration | 3PTZ3 [10626351] | MACROGENICS, INC. |
SEC | 0001125345 | MACROGENICS INC of DELAWARE |